1. A novel HER2-targeted liposomal formulation reduces the risk of hepatotoxicity induced by PEG-based anticancer drugs. (February 2020) Authors: De Martin, S.; Sarcognato, S.; Gabbia, D.; Canato, E.; Colognesi, M.; Cazzagon, N.; Guido, M.; Pasut, G. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e30 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Inhibiting NOXs with extra-virgin olive oil polyphenols as a strategy to prevent hepatic fibrogenesis. (February 2020) Authors: Gabbia, D.; Carpi, S.; Sarcognato, S.; Munari, S.; Colognesi, M.; Polini, B.; Digiacomo, M.; Manera, C.; Macchia, M.; Nieri, P.; Invernizzi, P.; Russo, F.P.; Floreani, A.; Cazzagon, N.; Guido, M.; De Martin, S. Journal: Digestive and liver disease Issue: Volume 52(2020)Supplement 1 Page Start: e65 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Preventing hepatic fibrogenesis with the two extra-virgin olive oil polyphenols tyrosol and hydroxytyrosol via NOX inhibition. (March 2021) Authors: Gabbia, D.; Carpi, S.; Sarcognato, S.; Colognesi, M.; Polini, B.; Digiacomo, M.; Manera, C.; Salsano, J.E.; Macchia, M.; Nieri, P.; Invernizzi, P.; Russo, F.P.; Floreani, A.; Cazzagon, N.; Guido, M.; De Martin, S. Journal: Digestive and liver disease Issue: Volume 53:(2021)Supplement 1 Page Start: S8 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. The dietary supplementation with brown seaweeds and chromium picolinate improves NAFLD and NASH by modulating lipid metabolism and inflammation. (March 2023) Authors: Gabbia, D.; Zanotto, I.; Sayaf, K.; Colognesi, M.; Sarcognato, S.; Guido, M.; Russo, F.P.; De Martin, S. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Tyrosol attenuates hepatic steatosis and fibrosis in a mouse model of NASH. (March 2023) Authors: Gabbia, D.; Sayaf, K.; Colognesi, M.; Zanotto, I.; Russo, F.P.; De Martin, S. Journal: Digestive and liver disease Issue: Volume 55(2023)Supplement 1 Page Start: S66 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗